Federal Register of Legislation - Australian Government

Primary content

PB 5 of 2020 Arrangements as made
This instrument amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011) to add, delete and make changes to drugs, forms, brands, responsible person codes, maximum quantities/amounts and repeats and the circumstances for prescribing various pharmaceutical benefits (including authority requirements).
Administered by: Health
Registered 31 Jan 2020
Tabling HistoryDate
Tabled HR04-Feb-2020
Tabled Senate04-Feb-2020
To be repealed 13 May 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

PB 5 of 2020

 

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2020 (No. 1)

 

National Health Act 1953

___________________________________________________________________________

 

I, BEN SLADIC, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 100(2) of the National Health Act 1953.

 

Dated         29 January 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BEN SLADIC          

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

 


___________________________________________________________________________

1          Name of Instrument

(1)          This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2020 (No. 1).

(2)          This Instrument may also be cited as PB 5 of 2020.

2          Commencement

This Instrument commences on 1 February 2020.

3          Amendment of National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011)

Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                                         

                                         


Schedule 1     Amendments

[1]             Schedule 1, Part 1, entry for Pemetrexed in the form Powder for I.V. infusion 100 mg (as disodium)

                           omit:

 

 

 

PEMETREXED-DRLA

RZ

MP

 

D

[2]             Schedule 1, Part 1, entry for Pemetrexed in the form Powder for I.V. infusion 500 mg (as disodium)

                           omit:

 

 

 

Pemetrexed DRLA

RZ

MP

 

D